Quantbot Technologies’s Meridian Bioscience Inc VIVO Stock Holding History

Quantbot Technologies’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,000	Closed	-$35K	–	1655
2019 Q2	$35K	Buy	+3,000	New	+$36.1K	﹤0.01%	963
2018 Q3	–	Sell	-900	Closed	-$14K	–	1636
2018 Q2	$14K	Sell	900 -500	-36%	-$7.46K	﹤0.01%	1097
2018 Q1	$19K	Buy	1,400 +100	+8%	+$1.48K	﹤0.01%	1071
2017 Q4	$18K	Buy	+1,300	New	+$19K	﹤0.01%	1076
2015 Q1	–	Sell	-5,845	Closed	-$96K	–	1423
2014 Q4	$96K	Buy	5,845 +2,645	+83%	+$45.4K	0.03%	665
2014 Q3	$56K	Buy	3,200 +2,200	+220%	+$43.2K	0.01%	961
2014 Q2	$20K	Buy	+1,000	New	+$20.5K	﹤0.01%	1042
2013 Q4	–	Sell	-100	Closed	-$2K	–	1203
2013 Q3	$2K	Buy	+100	New	+$2.33K	﹤0.01%	742

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Quantbot Technologies's VIVO Position: Q3 2019 in Review

Quantbot Technologies sold out of Meridian Bioscience Inc (VIVO) in Q3 2019, closing a stake of 3,000 shares — an estimated $35K sold.

Quantbot Technologies first reported a position in VIVO in Q3 2013 and held it in 8 quarters. The position peaked at $96K in Q4 2014. 163 funds tracked by Wall St. Rank hold VIVO as of Q3 2019.

Quantbot Technologies reported no remaining Meridian Bioscience Inc position as of Q3 2019 after selling out during the quarter.
Quantbot Technologies sold 3,000 Meridian Bioscience Inc shares in Q3 2019, an estimated $35K.
Quantbot Technologies first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 8 quarters.
Quantbot Technologies's Meridian Bioscience Inc position peaked at $96K in Q4 2014.
163 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2019.

Based on Quantbot Technologies's 13F filing for Q3 2019, filed 12 Nov 2019.